Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy D Henry

Showing results (231-240 of 573) with videos related to

Pageof 58
Sort By:
Circulation|September 28, 2011
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudicationMark A Creager, Jeffrey W Olin, Jill J F Belch, et al.
American Heart Journal|November 12, 2019
Admission Society for Cardiovascular Angiography and Intervention shock stage stratifies post-discharge mortality risk in cardiac intensive care unit patientsJacob C Jentzer, David A Baran, Sean van Diepen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 1, 2013
New generation drug-eluting stents for ST-elevation myocardial infarction: a new paradigm for safetyAnkit Garg, Bruce R Brodie, Thomas D Stuckey, et al.
Circulation. Cardiovascular Quality and Outcomes|November 6, 2014
Real-time decision support to guide percutaneous coronary intervention bleeding avoidance strategies effectively changes practice patternsCraig E Strauss, Brandon R Porten, Ivan J Chavez, et al.
Stem Cells Translational Medicine|June 13, 2020
CD34<sup>+</sup> cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory anginaGrace L Johnson, Timothy D Henry, Thomas J Povsic, et al.
Circulation. Cardiovascular Quality and Outcomes|February 18, 2021
Reliability and Validity of Current Approaches to Identification of Patients with ST-Segment-Elevation Myocardial InfarctionChristopher L Brown, Joseph Ebinger, Steven M Bradley, et al.
Circulation. Cardiovascular Quality and Outcomes|June 4, 2015
Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) StudyRobin Mathews, Eric D Peterson, Emily Honeycutt, et al.
American Heart Journal|May 15, 2018
Resource utilization and outcome among patients with selective versus nonselective troponin testingAlex R Campbell, Alexander J Rodriguez, David M Larson, et al.
Shock (Augusta, Ga.)|May 14, 2021
Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic ShockJacob C Jentzer, Kianoush B Kashani, Brandon M Wiley, et al.
Circulation. Cardiovascular Interventions|January 31, 2024
Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport TimesSean van Diepen, Yinggan Zheng, Janek M Senaratne, et al.
Pageof 58

Showing results (231-240 of 573) with videos related to

Sort By:
Pageof 58
Circulation|September 28, 2011
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudicationMark A Creager, Jeffrey W Olin, Jill J F Belch, et al.
American Heart Journal|November 12, 2019
Admission Society for Cardiovascular Angiography and Intervention shock stage stratifies post-discharge mortality risk in cardiac intensive care unit patientsJacob C Jentzer, David A Baran, Sean van Diepen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 1, 2013
New generation drug-eluting stents for ST-elevation myocardial infarction: a new paradigm for safetyAnkit Garg, Bruce R Brodie, Thomas D Stuckey, et al.
Circulation. Cardiovascular Quality and Outcomes|November 6, 2014
Real-time decision support to guide percutaneous coronary intervention bleeding avoidance strategies effectively changes practice patternsCraig E Strauss, Brandon R Porten, Ivan J Chavez, et al.
Stem Cells Translational Medicine|June 13, 2020
CD34<sup>+</sup> cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory anginaGrace L Johnson, Timothy D Henry, Thomas J Povsic, et al.
Circulation. Cardiovascular Quality and Outcomes|February 18, 2021
Reliability and Validity of Current Approaches to Identification of Patients with ST-Segment-Elevation Myocardial InfarctionChristopher L Brown, Joseph Ebinger, Steven M Bradley, et al.
Circulation. Cardiovascular Quality and Outcomes|June 4, 2015
Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) StudyRobin Mathews, Eric D Peterson, Emily Honeycutt, et al.
American Heart Journal|May 15, 2018
Resource utilization and outcome among patients with selective versus nonselective troponin testingAlex R Campbell, Alexander J Rodriguez, David M Larson, et al.
Shock (Augusta, Ga.)|May 14, 2021
Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic ShockJacob C Jentzer, Kianoush B Kashani, Brandon M Wiley, et al.
Circulation. Cardiovascular Interventions|January 31, 2024
Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport TimesSean van Diepen, Yinggan Zheng, Janek M Senaratne, et al.
Pageof 58